MDM2 and lung cancer: Two meta-analyses published in 2009 exploring the MDM2 SNP309 polymorphism and lung cancer risk yielded contradictory results (23,24) and other two meta-analyses investigating MDM2 SNP309 and tumor susceptibility published in 2011 also showed inconsistent results (25,26).